Home › Funds › Timothy G. Youngquist 2020 Irrevocable Trust › KNSA

Timothy G. Youngquist 2020 Irrevocable Trust position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

Timothy G. Youngquist 2020 Irrevocable Trust reported holding 34,341 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 0.52% of its reported portfolio and ranking #23 among its reported holdings. Timothy G. Youngquist 2020 Irrevocable Trust has disclosed KNSA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)34.34K sh
Reported value held$2.56M
Portfolio Weight0.52%
First reportedQ2 2026
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Timothy G. Youngquist 2020 Irrevocable Trust's KNSA position evolved

Timothy G. Youngquist 2020 Irrevocable Trust first disclosed a stake in KNSA in Q2 2026 at 34,341 shares (US$2.2M). The position peaked in Q3 2026 at 34,341 shares, worth US$2.6M. Across 2 filings, Timothy G. Youngquist 2020 Irrevocable Trust held the position steady without any share-count change. The most recent filing (Q3 2026) shows 34,341 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 34.34K $2.20M New
Q3 2026 34.34K $2.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 49 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has Timothy G. Youngquist 2020 Irrevocable Trust held KNSA?

Timothy G. Youngquist 2020 Irrevocable Trust has disclosed KNSA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Timothy G. Youngquist 2020 Irrevocable Trust's current position in KNSA?

As of Q3 2026, Timothy G. Youngquist 2020 Irrevocable Trust holds 34.34K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $2.56M, representing 0.52% of its reported portfolio and ranking #23.

Has Timothy G. Youngquist 2020 Irrevocable Trust been buying or selling KNSA?

In the latest 13F filing (Q3 2026), Timothy G. Youngquist 2020 Irrevocable Trust held unchanged its position in KNSA. The position peaked in Q3 2026 at 34.34K shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.